HF 3917
Introduction - 94th Legislature (2025 - 2026)
Posted on 03/02/2026 02:41 p.m.
1.5 1.6 1.7 1.8 1.9 1.10 1.11 1.12 1.13 1.14 1.15 1.16 1.17 1.18 1.19 1.20 1.21 1.22 2.1 2.2 2.3 2.4 2.5 2.6 2.7 2.8 2.9 2.10 2.11 2.12 2.13 2.14 2.15 2.16 2.17 2.18 2.19
A bill for an act
relating to health; modifying medication repository program procedures; amending
Minnesota Statutes 2024, section 151.555, subdivision 7.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:
Section 1.
Minnesota Statutes 2024, section 151.555, subdivision 7, is amended to read:
Subd. 7.
Standards and procedures for inspecting and storing donated drugs and
supplies.
(a) A pharmacist or authorized practitioner who is employed by or under contract
with the central repository or a local repository shall inspect all donated drugs and supplies
before the drug or supply is dispensed to determine, to the extent reasonably possible in the
professional judgment of the pharmacist or practitioner, that the drug or supply is not
adulterated or misbranded, has not been tampered with, is safe and suitable for dispensing,
has not been subject to a recall, and meets the requirements for donation. If a local repository
receives drugs and supplies from the central repository, the local repository does not need
to reinspect the drugs and supplies.
(b) The central repository and local repositories shall store donated drugs and supplies
in a secure storage area under environmental conditions appropriate for the drug or supply
being stored. Donated drugs and supplies may not be stored with nondonated inventory.
(c) The central repository and local repositories shall dispose of all drugs and medical
supplies that are not suitable for donation in compliance with applicable federal and state
statutes, regulations, and rules concerning hazardous waste.
(d) In the event that controlled substances or drugs that can only be dispensed to a patient
registered with the drug's manufacturer are shipped or delivered to a central or local repository
for donation, the shipment delivery must be documented by the repository and returned
immediately to the donor or the donor's representative that provided the drugs.
(e) Each repository must develop drug and medical supply recall policies and procedures.
If a repository receives a recall notification, the repository shall destroy all of the drug or
medical supply in its inventory that is the subject of the recall and complete a record of
destruction form in accordance with paragraph (f). If a drug or medical supply that is the
subject of a Class I or Class II recall has been dispensed, the repository shall immediately
notify the recipient of the recalled drug or medical supply. A drug that potentially is subject
to a recall need not be destroyed if its packaging bears a lot number and that lot of the drug
is not subject to the recall. If no lot number is on the drug's packaging, it must be destroyed.
(f) A record of destruction ofnew text begin acceptednew text end donated drugs and supplies that are not dispensed
under subdivision 8deleted text begin , are subject to a recall under paragraph (e), or are not suitable for
donationdeleted text end new text begin or are subject to a recall under paragraph (e)new text end shall be maintained by the repository
for at least two years. deleted text begin For each drug or supply destroyed,deleted text end The record shall include the
following information:
(1) the date of destruction;
(2) the name, strength, and quantity of the drug destroyed; and
(3) the name of the person or firm that destroyed the drug.
No other record of destruction is required.